Cargando…

Unique cytologic features of thyroiditis caused by immune checkpoint inhibitor therapy for malignant melanoma

Blockade of immune checkpoint molecules to reverse cancer-induced immune suppression can improve anti-tumor immune responses in cancer patients. Monoclonal antibodies targeting two such molecules, Programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte associated protein 4 (CTLA-4) have sh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angell, Trevor E., Min, Le, Wieczorek, Tad J., Hodi, F. Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chongqing Medical University 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879785/ https://www.ncbi.nlm.nih.gov/pubmed/29619406 http://dx.doi.org/10.1016/j.gendis.2017.11.002

Ejemplares similares

Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate Thyroid Nodules
por: Goldner, Whitney S., et al.
Publicado: (2019)

Reduced Tumor Size of Untreated Papillary Thyroid Carcinoma After Immune Checkpoint Inhibitor–Induced Thyroiditis
por: Chen, Dennis H., et al.
Publicado: (2023)

Immunity to the melanoma inhibitor of apoptosis protein (ML-IAP; livin) in patients with malignant melanoma
por: Zhou, Jun, et al.
Publicado: (2011)

The Impact of Hashimoto Thyroiditis on Thyroid Nodule Cytology and Risk of Thyroid Cancer
por: Silva de Morais, Nathalie, et al.
Publicado: (2019)

OR19-5 The Impact Of High Dose Glucocorticoids On The Outcome Of Immune Checkpoint Inhibitor-related Thyroid Disorders And The Baseline TSH As A Predictive Biomarker
por: Min, Le, et al.
Publicado: (2019)

Checkpoint inhibitors for malignant melanoma: a systematic review and meta-analysis
por: Karlsson, Adam K, et al.
Publicado: (2017)

Infliximab for Steroid-Refractory Immune Checkpoint Inhibitor-Induced Acute Pancreatitis
por: Townsend, Matthew J., et al.
Publicado: (2023)

Corticosteroids and immune checkpoint blockade
por: Min, Le, et al.
Publicado: (2015)

Long- versus short-interval follow-up of cytologically benign thyroid nodules: a prospective cohort study
por: Medici, Marco, et al.
Publicado: (2016)

Targeted and Checkpoint Inhibitor Therapy of Metastatic Malignant Melanoma in Germany, 2000–2016
por: Hellmund, Peter, et al.
Publicado: (2020)

Clinical Characteristics and Treatment Response With Checkpoint Inhibitors in Malignant Melanoma of the Vulva and Vagina
por: Wohlmuth, Christoph, et al.
Publicado: (2020)

SAT-473 Thyroid Dysfunction in a Patient with Malignant Melanoma Treated with Immune Checkpoint Blockade
por: Gupta, Shaveta, et al.
Publicado: (2020)

Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma
por: Changizzadeh, Pouyan N., et al.
Publicado: (2017)

Activity of the Heat Shock Protein 90 Inhibitor Ganetespib in Melanoma
por: Wu, Xinqi, et al.
Publicado: (2013)

Artificial Intelligence for Pre-operative Diagnosis of Malignant Thyroid Nodules Based on Sonographic Features and Cytology Category
por: Jassal, Karishma, et al.
Publicado: (2022)

Thyroid nodules with highly suspicious ultrasonographic features, but with benign cytology on two occasions: is malignancy still possible?
por: Rosário, Pedro Weslley, et al.
Publicado: (2016)

Metastatic malignant melanoma intraoperative imprint cytology of brain tumor
por: Azarpira, Negar, et al.
Publicado: (2012)

Malignant melanoma of conjunctiva: Diagnosis on fine-needle aspiration cytology
por: Kishore, Manjari, et al.
Publicado: (2018)

Immune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know
por: Braschi-Amirfarzan, Marta, et al.
Publicado: (2017)

Role of morphometry in the cytological differentiation of benign and malignant thyroid lesions
por: Khatri, Pallavi, et al.
Publicado: (2017)

Utility of microdissected cytology smears for molecular analysis of thyroid malignancy
por: Kumar, Gyanendra, et al.
Publicado: (2018)

Biomarkers for Immune Checkpoint Inhibitors in Melanoma
por: Kitano, Shigehisa, et al.
Publicado: (2018)

Checkpoint inhibitors in hematological malignancies
por: Ok, Chi Young, et al.
Publicado: (2017)

Causes of Pruritus in Patients Treated With Immune Checkpoint Inhibitors for Melanomas or Skin Carcinomas
por: Salinas, Nadia, et al.
Publicado: (2021)

Identification of RORg(+)T Cells as Key Players in Thyroid Autoimmunity From Checkpoint Immunotherapy
por: Lechner, Melissa G, et al.
Publicado: (2021)

Inhibition of Immune Checkpoints and Vascular Endothelial Growth Factor as Combination Therapy for Metastatic Melanoma: An Overview of Rationale, Preclinical Evidence, and Initial Clinical Data
por: Ott, Patrick A., et al.
Publicado: (2015)

Cytologic features of primary monophasic synovial sarcoma of the thyroid gland
por: Park, Chang-Soo, et al.
Publicado: (2017)

Malignancy Rates of Thyroid Cytology: Cyst Fluid Benign or Non-Diagnostic?
por: Güney, Güven, et al.
Publicado: (2017)

Indeterminate thyroid cytology: detecting malignancy using analysis of nuclear images
por: Hayashi, Caroline Y, et al.
Publicado: (2021)

Thyroid Nodule Management: Thyroid-Stimulating Hormone, Ultrasound, and Cytological Classification System for Predicting Malignancy
por: Al Dawish, Mohamed Abdulaziz, et al.
Publicado: (2018)

Risk of malignancy in cytologically indeterminate thyroid nodules harboring thyroid stimulating hormone receptor mutations
por: Whitmer, Dorota, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Melanoma and HIV Infection
por: Marra, Antonio, et al.
Publicado: (2017)

Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma
por: Petrova, Vera, et al.
Publicado: (2020)

Efficacy of immune checkpoint inhibitors for in-transit melanoma
por: Nan Tie, Emilia, et al.
Publicado: (2020)

Update on Immune Checkpoint Inhibitors for Conjunctival Melanoma
por: Sa, Ho-Seok, et al.
Publicado: (2022)

Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes
por: Baca, Sylvan C., et al.
Publicado: (2017)

Molecular and Clinical Features of Hospital Admissions in Patients with Thoracic Malignancies on Immune Checkpoint Inhibitors
por: Zhao, Dan, et al.
Publicado: (2021)

Checkpoint inhibitors in the treatment of urological malignancies
por: Popovic, Lazar S, et al.
Publicado: (2017)

Sarcoid-like Granulomatosis Associated with Immune Checkpoint Inhibitors in Melanoma
por: Melin, Audrey, et al.
Publicado: (2022)

Case Report: Prolonged Anorexia With Nausea Caused by Immune Checkpoint Inhibitors for Malignant Melanoma Treated Using Kampo Medicines Bukuryoingohangekobokuto and Ninjin’yoeito
por: Takayama, Shin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ldih364mlh99vahj2o5tla0tfo